1.
Objective: To predict the stability of Compound angelica powder for injection and ensure the safety and utility in clinical medication.
目的:预测复方当归粉针剂的稳定性以保证临床用药安全有效。
2.
The investigation of actions and factors analysis of irrational drug use in clinic
临床不安全用药行为研究及成因分析
3.
The Role of Clinical Physicians in the Safety Evaluation of Traditional Chinese Medicine
临床医师在中药安全性评价中的作用
4.
A Brife Discussion on the Important Role of Pharmacists in Safe Medication
谈药学人员在临床安全用药中的重要作用
5.
Adverse Reaction of Commonly Used Anti-Hypertensives and Safety Countermeasure on Clinic
临床常用降压药物的不良反应及安全对策
6.
Safety of drug-eluting stent versus bare stent in clinical application
药物洗脱支架与裸支架临床应用的安全性比较
7.
Analysis of Clinical Safety Application of The Third Generation Cefazolin
第三代头孢菌素类抗生素临床安全用药分析
8.
Concentration Monitoring in Whole Blood, Clinical Application and Safety Evaluation of Sirolimus in Allo-HSCT Patients;
西罗莫司在allo-HSCT患者的全血药浓度监测、临床应用和安全性评价
9.
Objective To evaluate the clinical efficacy and safety of EXCEL drug-eluting stents.
目的评价国产EXCEL雷帕霉素药物洗脱支架临床应用的安全性及疗效。
10.
Problems in preclinical safety evaluation of the new TCM external preparations for rheumatism,orthopedics and surgery
风湿、骨科、外科外用中药制剂临床前安全性评价中需关注的问题
11.
Consideration on nonclinical evaluation for the conduct of human clinical trails and marketing authorization for new anticancer drugs
抗肿瘤新药临床试验和上市的非临床安全性评价要点
12.
Consideration About Current Nonclinical Safety Evaluation of Traditional Chinese Medicine and Naturally Occurring Drug from FDA’s Botanical Drug Registration Case
从美国植物药注册实例看我国中药、天然药物非临床安全性评价
13.
Conclusion The cefoxitin sodium for injection is safe.
结论头孢西丁钠临床静脉和肌肉注射给药安全。
14.
Pharmacodynamic Studies and Preclinical Safety Evaluations of Dehydrocavidine;
脱氢卡维汀药效学研究及临床前安全性评价
15.
Statistical Method for Safety Assessment in the Clinical Researches of New Drugs;
新药临床研究中安全性评价的统计方法
16.
Studies on Clinical Pharmacokinetics, Tolerance and Safety of D-polymannuronicate
D-聚甘酯临床药代动力学及安全耐受性研究
17.
Technical requirements from ICH for Preclinical Cardiac Safety Evaluation of Pharmaceuticals
ICH对药物临床前心脏安全性评价的技术要求
18.
Characteristics and clinical security of coronary artery drug-eluting stent
冠状动脉药物洗脱支架的特点及其临床安全性